Red blood cell hemolysis during processing

Area of Science:

• Transfusion Medicine
• Hematology
• Biocompatibility

Background:

• Red blood cell (RBC) hemolysis, the breakdown of RBCs, can occur in stored units for transfusion.
• Released free hemoglobin can exceed haptoglobin binding capacity, leading to hemoglobinemia and clinical complications.
• Causes of abnormal hemolysis are multifactorial, including processing, storage, bacterial factors, immune responses, and intrinsic RBC defects.

Purpose of the Study:

• To highlight the clinical significance of RBC hemolysis in transfusion medicine.
• To discuss the various causes and contributing factors to RBC hemolysis.
• To emphasize the importance of process control in minimizing hemolysis and associated wastage.

Main Methods:

• Review of existing literature on RBC hemolysis and its causes.
• Analysis of factors influencing RBC integrity during processing and storage.
• Discussion of current standards and acceptable levels of hemolysis.

Main Results:

• Hemolysis is characterized by free hemoglobin release, leading to plasma discoloration and potential hemoglobinemia.
• Multiple factors can induce hemolysis, including improper handling, storage, bacterial hemolysins, antibodies, and RBC membrane defects.
• Established acceptable hemolysis levels vary, with North America lacking a definitive standard (1% used for biocompatibility) and Europe setting it at 0.8%.

Conclusions:

• Adequate control over RBC preparation processes is essential to minimize hemolysis.
• Careful evaluation of manufacturing and storage procedures can significantly reduce RBC wastage.
• Implementing stricter controls can improve the safety and efficacy of red blood cell transfusions.